South San Francisco, CA, United States of America

Alexandre Tumlinson

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Twenty Twenty Therapeutics LLC. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandre Tumlinson. Retrieved from https://idiyas.com/inventor/alexandre-tumlinson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alexandre Tumlinson

Introduction

Alexandre Tumlinson is a notable inventor based in South San Francisco, CA. He has made significant strides in the field of ophthalmic devices, showcasing his expertise and creativity through his innovative designs. With a focus on improving medical technology, Tumlinson has developed a unique device that enhances the process of intravitreal injections.

Latest Patents

Tumlinson holds a patent for an "Intravitreal injection device with combined vitreous sampling." This ophthalmic device features a housing designed to hold an injectant chamber, which stores the injectant. It includes a plunger within the injectant chamber and a stopper attached to the distal portion of the plunger. Additionally, the device is equipped with a hypodermic needle at the distal end of the housing and a sample chamber located adjacent to the distal end. The design allows for efficient material sampling and injectant dispensing, making it a valuable tool in ophthalmology.

Career Highlights

Throughout his career, Tumlinson has demonstrated a commitment to advancing medical technology. His work at Twenty Twenty Therapeutics LLC has positioned him as a key player in the development of innovative solutions for eye care. His patent reflects his dedication to improving patient outcomes through enhanced medical devices.

Collaborations

Tumlinson collaborates with Ellen Kaplan, contributing to the innovative environment at Twenty Twenty Therapeutics LLC. Their combined efforts aim to push the boundaries of what is possible in ophthalmic technology.

Conclusion

Alexandre Tumlinson's contributions to the field of ophthalmic devices exemplify the impact of innovation in healthcare. His patented intravitreal injection device represents a significant advancement in medical technology, showcasing his dedication to improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…